← Leaderboards
Raul San Jose Estepar
Brigham And Women'S Hospital
$11,331,173
Attributed
$16,203,491
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,203,491 · 8
By mechanism
R01$14,746,574 · 5
K25$764,985 · 1
R21$691,932 · 2
Top collaborators
- George R Washko9 shared
- Amil M Shah4 shared
- Alejandro Diaz2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Edward P Ingenito$10,382,683
- Edwin K Silverman$89,199,838
- Farbod Nicholas Rahaghi$4,904,428
- Marcelo F Di Carli$12,559,552
- George R Washko$16,445,968
Others in their field
Top investigators on “Scanning”
- Michael W Weiner · Northern California Institute Res &Educ$129,636,763
- James D Crapo · University Of Colorado Denver$97,835,516
- David Heimbrook · Leidos Biomedical Research, Inc.$94,143,783
- Stephen S. Rich · University Of Alabama At Birmingham$80,914,612
- Lee Hamm · Tulane University Of Louisiana$77,552,437
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
Research focus
ScanningLungChestX-Ray Computed TomographyImageCohortBaseAffectPulmonary EmphysemaSmokerUnited StatesLeadMeasurementMorphologyBlood VesselsSeveritiesInflammatoryChronic Obstructive Airway DiseasePhenotypeRespiratory PhysiologyValidationCommunitiesInvestigationGenetic Association
Grant awards (33)
Clinical implications and Proteomics of Bronchiectasis Progression in Smokers$882,727
R01 · FY2025 · HL
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly$672,558
R01 · FY2025 · HL
Clinical implications and Proteomics of Bronchiectasis Progression in Smokers$877,608
R01 · FY2024 · HL
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly$672,858
R01 · FY2024 · HL
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly$795,260
R01 · FY2023 · HL · contact PI
Prognostic Markers of Emphysema Progression$677,739
R01 · FY2023 · HL · contact PI
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly$815,189
R01 · FY2022 · HL
Prognostic Markers of Emphysema Progression$687,975
R01 · FY2022 · HL · contact PI
CT and CXR Phenotyping Platform for Assessing COVID-19 Susceptibility and Severity$272,528
R21 · FY2022 · LM · contact PI
Prognostic Markers of Emphysema Progression$709,369
R01 · FY2021 · HL · contact PI
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers$676,308
R01 · FY2021 · HL
CT and CXR Phenotyping Platform for Assessing COVID-19 Susceptibility and Severity$155,730
R21 · FY2021 · LM · contact PI
Prognostic Markers of Emphysema Progression$730,139
R01 · FY2020 · HL · contact PI
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers$676,308
R01 · FY2020 · HL
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers$682,441
R01 · FY2019 · HL
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers$728,442
R01 · FY2018 · HL
CT-based Predictors of ILA Progression in COPDGene$134,250
R21 · FY2018 · HL · contact PI
Airway Inspector: a chest imaging biomarker software platform for COPD$443,750
R01 · FY2017 · HL · contact PI
The clinical impact of pulmonary vascular remodeling in smokers$436,210
R01 · FY2017 · HL
CT-based Predictors of ILA Progression in COPDGene$129,424
R21 · FY2017 · HL · contact PI
Airway Inspector: a chest imaging biomarker software platform for COPD$443,750
R01 · FY2016 · HL · contact PI
The clinical impact of pulmonary vascular remodeling in smokers$436,358
R01 · FY2016 · HL
The clinical impact of pulmonary vascular remodeling in smokers$462,911
R01 · FY2015 · HL
Airway Inspector: a chest imaging biomarker software platform for COPD$436,170
R01 · FY2015 · HL · contact PI
The clinical impact of pulmonary vascular remodeling in smokers$454,695
R01 · FY2014 · HL
Airway Inspector: a chest imaging biomarker software platform for COPD$432,732
R01 · FY2014 · HL · contact PI
CT-based Phenotype for Airway Remodeling in COPD based on Airway Wall Density$153,157
K25 · FY2014 · HL · contact PI
The clinical impact of pulmonary vascular remodeling in smokers$474,764
R01 · FY2013 · HL
Airway Inspector: a chest imaging biomarker software platform for COPD$440,313
R01 · FY2013 · HL · contact PI
CT-based Phenotype for Airway Remodeling in COPD based on Airway Wall Density$153,157
K25 · FY2013 · HL · contact PI
CT-based Phenotype for Airway Remodeling in COPD based on Airway Wall Density$153,157
K25 · FY2012 · HL · contact PI
CT-based Phenotype for Airway Remodeling in COPD based on Airway Wall Density Pow$152,757
K25 · FY2011 · HL · contact PI
CT-based Phenotype for Airway Remodeling in COPD based on Airway Wall Density Pow$152,757
K25 · FY2010 · HL · contact PI